GEM 21S®
Periodontal and peri-implant bone regeneration, intrabony defects, furcation defects
ApprovedActive
Key Facts
Indication
Periodontal and peri-implant bone regeneration, intrabony defects, furcation defects
Phase
Approved
Status
Active
Company
About Lynch Biologics
Lynch Biologics is a commercial-stage biotechnology company specializing in growth-factor enhanced matrices for dental and periodontal regenerative surgery. Its core asset, GEM 21S®, is the first and only FDA-approved off-the-shelf source of purified rhPDGF-BB for bone and soft tissue regeneration in oral applications. The company leverages the body's natural healing mechanisms by delivering a key signaling protein to attract stem cells and stimulate angiogenesis. As part of Geistlich, it benefits from an expanded commercial footprint and shared expertise in regenerative solutions.
View full company profile